Yu Wenxia, You Xiaoyan, Luo Wei
Department of Clinical Laboratory, Qingdao Municipal Hospital, Qingdao, China.
Front Med (Lausanne). 2024 Aug 15;11:1448841. doi: 10.3389/fmed.2024.1448841. eCollection 2024.
To comprehensively assess the global burden of syphilis and related risk factors over 1990-2021, forecast future disease trends, and understand the impact of syphilis on global health.
Global Burden of Disease Study 2021 (GBD 2021) data were used for age-, sex-, and region-stratified analysis of the numbers and age-standardized rates (per 100,000 population) of syphilis incidence, prevalence, deaths, and disability-adjusted life years (DALYs). Next, a differential analysis of syphilis risk factors was performed. Finally, trends for years after 2021 were predicted using Bayesian age-period-cohort (BAPC) prediction models.
In 2021, the total number of syphilis prevalence globally was 70,541,482.80 (95% uncertainty interval: 54,910,897.66-88,207,651.97), with the highest numbers noted in Central Sub-Saharan Africa [4,622.60 (95% uncertainty interval: 3,591.97-5,753.45)]. Over 1990-2021, the global age-standardized prevalence and incidence rates increased, whereas the age-standardized death and DALY rates decreased. Among all groups, infants aged <5 years demonstrated the highest age-standardized DALY rates. Moreover, the lower the sociodemographic index (SDI), the higher was the age-standardized rate. The primary factor contributing to syphilis disease burden was identified to be unsafe sex. BAPC analysis revealed an overall increase in age-standardized prevalence rate in the <5-year age group over 1990-2035, and the highest age-standardized prevalence rate occurred in the 25-34-year age group.
Between 1990 and 2021, syphilis occurrence and prevalence increased consistently. Projections indicated a continual increase in syphilis incidence in children aged <5 years, and age-standardized prevalence rates were the highest in adults aged 25-34 years. Our results regarding the epidemiological trends of syphilis and its variations across regions, age groups, and sexes may aid policymakers in addressing the global impact of the disease effectively.
全面评估1990 - 2021年梅毒的全球负担及相关风险因素,预测未来疾病趋势,并了解梅毒对全球健康的影响。
采用2021年全球疾病负担研究(GBD 2021)数据,对梅毒发病率、患病率、死亡数和伤残调整生命年(DALYs)按年龄、性别和地区进行分层分析,计算每10万人中的发病数、患病率、死亡数及年龄标准化率。接下来,对梅毒风险因素进行差异分析。最后,使用贝叶斯年龄 - 时期 - 队列(BAPC)预测模型预测2021年后的趋势。
2021年,全球梅毒患病率总数为70541482.80(95%不确定区间:54910897.66 - 88207651.97),其中撒哈拉以南非洲中部地区的患病率最高[4622.60(95%不确定区间:3591.97 - 5753.45)]。在1990 - 2021年期间,全球年龄标准化患病率和发病率上升,而年龄标准化死亡率和伤残调整生命年率下降。在所有群体中,5岁以下婴儿的年龄标准化伤残调整生命年率最高。此外,社会人口指数(SDI)越低,年龄标准化率越高。确定导致梅毒疾病负担的主要因素是不安全的性行为。BAPC分析显示,在1990 - 2035年期间,5岁以下年龄组的年龄标准化患病率总体呈上升趋势,年龄标准化患病率最高的是25 - 34岁年龄组。
1990年至2021年期间,梅毒的发病率和患病率持续上升。预测表明,5岁以下儿童的梅毒发病率将持续增加,年龄标准化患病率在25 - 34岁成年人中最高。我们关于梅毒流行病学趋势及其在不同地区、年龄组和性别中的变化结果,可能有助于政策制定者有效应对该疾病的全球影响。